NCT04216732 Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
| NCT ID | NCT04216732 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Advanced Thyroid Gland Medullary Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,030 participants |
| Start Date | 2020-01-10 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,030 participants in total. It began in 2020-01-10 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
Eligibility Criteria
Inclusion Criteria: * Aims 1 and 2: A diagnosis of MTC * Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment * Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team * Aim 3: A current registrant in the MTCR
Contact & Investigator
Elizabeth G Grubbs
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT04216732 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Advanced Thyroid Gland Medullary Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04216732 currently recruiting?
Yes, NCT04216732 is actively recruiting participants. Contact the research team at eggrubbs@mdanderson.org for enrollment information.
Where is the NCT04216732 trial being conducted?
This trial is being conducted at San Francisco, United States, Houston, United States.
Who is sponsoring the NCT04216732 clinical trial?
NCT04216732 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Elizabeth G Grubbs at M.D. Anderson Cancer Center. The trial plans to enroll 2,030 participants.